Anti-tumor effects and mechanism of GA-13315, a novel gibberellin derivative, in human lung adenocarcinoma: an in vitro and in vivo study.
Conclusions: This study suggests that GA-13315 can be considered as a promising chemotherapeutic agent with anticancer activity in treatment of lung cancer in future.
PMID: 30651744 [PubMed - in process]
Source: Cellular and Molecular Biology Letters - Category: Biochemistry Authors: Xie L, Chen Y, Chen J, Zhang H, Liao Y, Zhou Y, Zhou L, Qing C Tags: Cell Mol Biol Lett Source Type: research
More News: Adenocarcinoma | Biochemistry | Biology | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Genetics | Lung Cancer | Lymphoma | Molecular Biology | Study | Toxicology | Urology & Nephrology